WOOJUNG BIO, Inc. (KOSDAQ:215380)
1,770.00
0.00 (0.00%)
At close: Sep 19, 2025
WOOJUNG BIO Revenue
WOOJUNG BIO had revenue of 7.09B KRW in the quarter ending June 30, 2025, a decrease of -40.17%. This brings the company's revenue in the last twelve months to 36.60B, down -18.23% year-over-year. In the year 2024, WOOJUNG BIO had annual revenue of 43.20B with 11.87% growth.
Revenue (ttm)
36.60B
Revenue Growth
-18.23%
P/S Ratio
0.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 43.20B | 4.58B | 11.87% |
Dec 31, 2023 | 38.62B | -8.30B | -17.70% |
Dec 31, 2022 | 46.92B | 15.68B | 50.20% |
Dec 31, 2021 | 31.24B | -6.11B | -16.35% |
Dec 31, 2020 | 37.34B | 5.05B | 15.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |